171 related articles for article (PubMed ID: 31943621)
1. Review of gout clinic in a tertiary hospital setting.
Leonardo N; Lester S; Whittle S; Rischmueller M
Intern Med J; 2020 Jan; 50(1):117-120. PubMed ID: 31943621
[TBL] [Abstract][Full Text] [Related]
2. Management of Gout in a Hospital Setting: A Lost Opportunity.
Wright S; Chapman PT; Frampton C; O'Donnell JL; Raja R; Stamp LK
J Rheumatol; 2017 Oct; 44(10):1493-1498. PubMed ID: 28765252
[TBL] [Abstract][Full Text] [Related]
3. Lessons and pitfalls from the 2020 Gout Clinical Practice Guideline presented in Atlanta at the ACR 2019.
Jansen TL; Janssen M
Clin Rheumatol; 2020 Jun; 39(6):2011-2016. PubMed ID: 32318971
[TBL] [Abstract][Full Text] [Related]
4. A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift.
Khanna P; Khanna D; Storgard C; Baumgartner S; Morlock R
Postgrad Med; 2016 Jan; 128(1):34-40. PubMed ID: 26578028
[TBL] [Abstract][Full Text] [Related]
5. New therapeutic approach to hyperuricemia and gout in the light of recommendations.
Lioté F
Joint Bone Spine; 2016 Jul; 83(4):376-80. PubMed ID: 27085801
[No Abstract] [Full Text] [Related]
6. Inpatient management of gout in a New Zealand hospital: a retrospective audit.
Kennedy NJ; Healy PJ; Harrison AA
Int J Rheum Dis; 2016 Feb; 19(2):205-10. PubMed ID: 25873399
[TBL] [Abstract][Full Text] [Related]
7. Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients.
Janssen CA; Jansen TLTA; Oude Voshaar MAH; Vonkeman HE; van de Laar MAFJ
Rheumatol Int; 2017 Sep; 37(9):1435-1440. PubMed ID: 28748426
[TBL] [Abstract][Full Text] [Related]
8. Achieving serum urate targets in gout: an audit in a gout-oriented rheumatology practice.
Corbett EJM; Pentony P; McGill NW
Int J Rheum Dis; 2017 Jul; 20(7):894-897. PubMed ID: 28205336
[TBL] [Abstract][Full Text] [Related]
9. Chronic gout: Barriers to effective management.
Rogenmoser S; Arnold MH
Aust J Gen Pract; 2018 Jun; 47(6):351-356. PubMed ID: 29966174
[TBL] [Abstract][Full Text] [Related]
10. Adherence and persistence to urate-lowering therapies in the Irish setting.
McGowan B; Bennett K; Silke C; Whelan B
Clin Rheumatol; 2016 Mar; 35(3):715-21. PubMed ID: 25409858
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of the randomized evaluation of an Ambulatory Care Pharmacist-Led Intervention to Optimize Urate Lowering Pathways (RAmP-UP) Study.
Coburn BW; Cheetham TC; Rashid N; Chang JM; Levy GD; Kerimian A; Low KJ; Redden DT; Bridges SL; Saag KG; Curtis JR; Mikuls TR
Contemp Clin Trials; 2016 Sep; 50():106-15. PubMed ID: 27449546
[TBL] [Abstract][Full Text] [Related]
12. The challenges of managing gout in primary care: Results of a best-practice audit.
Stamp LK; Chapman P; Hudson B; Frampton C; Hamilton G; Judd A
Aust J Gen Pract; 2019 Sep; 48(9):631-637. PubMed ID: 31476837
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive dietary education in treated gout patients does not further improve serum urate.
Holland R; McGill NW
Intern Med J; 2015 Feb; 45(2):189-94. PubMed ID: 25495503
[TBL] [Abstract][Full Text] [Related]
14. Evaluating appropriate use of prophylactic colchicine for gout flare prevention.
George M; Pullman-Mooar S; Hussain F; Schumacher HR
Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1258-62. PubMed ID: 24376081
[TBL] [Abstract][Full Text] [Related]
15. Opportunities for improving medication use and monitoring in gout.
Singh JA; Hodges JS; Asch SM
Ann Rheum Dis; 2009 Aug; 68(8):1265-70. PubMed ID: 18701554
[TBL] [Abstract][Full Text] [Related]
16. Treatment of gout.
Cohen MG
Intern Med J; 2011 Jan; 41(1a):70-1. PubMed ID: 21265967
[No Abstract] [Full Text] [Related]
17. Effectiveness of a pharmacist-based gout care management programme in a large integrated health plan: results from a pilot study.
Goldfien RD; Ng MS; Yip G; Hwe A; Jacobson A; Pressman A; Avins AL
BMJ Open; 2014 Jan; 4(1):e003627. PubMed ID: 24413343
[TBL] [Abstract][Full Text] [Related]
18. Updates on the treatment of gout, including a review of updated treatment guidelines and use of small molecule therapies for difficult-to-treat gout and gout flares.
Soskind R; Abazia DT; Bridgeman MB
Expert Opin Pharmacother; 2017 Aug; 18(11):1115-1125. PubMed ID: 28658988
[TBL] [Abstract][Full Text] [Related]
19. Management of Gout.
Anderson IJ; Davis AM; Jan RH
JAMA; 2021 Dec; 326(24):2519-2520. PubMed ID: 34962547
[No Abstract] [Full Text] [Related]
20. What Is the Evidence for Treat-to-Target Serum Urate in Gout?
Bursill D; Dalbeth N
Curr Rheumatol Rep; 2018 Mar; 20(3):11. PubMed ID: 29516287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
